The latest research study “Clinical Trial Management Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global clinical trial management systems market size reached a value of US$ 927.4 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 1,840.40 Million by 2027 exhibiting a CAGR of 11.50% during 2022-2027.
A clinical trial management system (CTMS) represents a suite of tools that are utilized for effectively planning, tracking, and managing clinical trials in medical research studies. It primarily involves start-up timelines, reporting protocol information and accrual data, financial management, standardized billing processes and invoicing, subject visit tracking, etc. Moreover, CTMS standardizes clinical and operational data via advanced visualization and analytical techniques. Consequently, clinical trial management systems are extensively used by medical researchers to analyze, manage, and facilitate the transfer of patient data.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/clinical-trial-management-systems-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Clinical Trial Management Systems Market Trends and Drivers:
The escalating demand for personalized treatments and regenerative medicines is primarily driving the clinical trial management systems market. In line with this, the increasing usage of CTMS as a centralized and web-based enterprise resource to support complex clinical research studies in real-time is further catalyzing the market growth.
Additionally, the rising prevalence of new infectious and chronic diseases is propelling the adoption of advanced diagnostics and drug discovery tools, which, in turn, is acting as another significant growth-inducing factor.
Besides this, the inflating need for cloud-based CTMS to conduct trials of medical products, monitor the administration of vaccines, manage patient data, etc., on account of the sudden outbreak of the COVID-19 pandemic, is also augmenting the global market.
Furthermore, numerous technological advancements, including automated eClinical solutions for improving productivity, study reconciliation, data quality, etc., are anticipated to fuel the clinical trial management systems market over the forecasted period.
Global Clinical Trial Management Systems Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Advarra Inc., ArisGlobal LLC, BioClinica Inc., DataTrak International Inc., DZS Clinical Services Inc. (WDB Holdings Co. Ltd.), International Business Machines Corporation, Medidata Solutions Inc. (Dassault Systèmes SE), MedNet Solutions Inc., Oracle Corporation, Parexel International Corporation, RealTime Software Solutions LLC and Veeva Systems Inc.
The report has segmented the market on the basis of region, component, deployment mode and end user.
Breakup by Component:
Breakup by Deployment Mode:
Breakup by End User:
- Contract Research Organization
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/clinical-trial-management-systems-market
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800